Podcast

The KRFI Podcasts and Publications are current event of the psychedelic scientific reports. KRFI is a medical and drug research institute dedicated to ibogaine and psychedelic for global mental health security and neglected diseases research.

​

 

The KRFI Podcast is a space to address diverse topics utilizing Natural plant medicine by open dialogue and conversations around the current evidence based clinical studies of psychedelics and Ibogaine, and the scientific formulations and enhancement of psychedelics. These medicinal plant bioactive in the use of entheogenic spiritual practices and the traditional medicines for mental health therapies are of cultural heritage and diversity that has impacted human mental health and spirituality throughout our history.

​

 

Our dialogues aim to bring scientists and industrialist together to challenge the skepticism of the entheogenic spiritual practices are often associated with shamanism, and traditional practitioners in anthropological and historical use of the psychedelics has extensive applications for the mental health therapeutics beyond spiritual and entheogenic practices.

​

 

In the present times of national and global opioid pandemic, ibogaine and psychedelics has shown efficacy for opioid and substance use disorder and its anti-addiction properties as therapeutics has entered diverse clinical trials globally. The national opioid abatement funds has been established addressing the private public sector partnership principals in Opioid Abatement Matching Fund (OAMF) to share the burdens of Opioid Pandemic and its Mental Health Securities as the growing number of in-state stakeholders and to high-performance industrial and corporate responsibilities in the Access for Benefit Sharing (ABS) and Off-Set environmental community impact for local US and global stakeholders in a sustainable business partnership in the future of safeguarding our community and people.

​

 

It goes to show that while our differences are addressing the decriminalization of the 1970’s War on Drug that brought on the US and global policies beyond the wisdom of the natural product medicine, our lives disrupted with social inequity and incarcerations, and creation for the mental health discord and scheduled 1 grouping of all psychedelic natural products in the controlled substance with over 50 years restriction on necessity of evidence based scientific challenges of the natural products psychedelic uses.

​

 

Throughout our humanity and mythical historical aspects as a de fact that psychedelics has ultimately unveiled through plant medicine and the psychospiritual portal for mental health. In the awake of our current Opioid Pandemic and the need for national mental health security, the state of Opioid Abatement Funds in finding an civil and public private sector partnership for the Opioid Abatement Matching Fund (OAMF) for the ibogaine and psychedelic medicine. Currently the world is seeking new national and global mental health security - for a healthy community that is reflection of our inner beings within all of us.

​

 

The interviews are in reporting of the present progress of psychedelic Act, New Natural Medicine Health Act, and Decriminalization of Psychedelic Bill and national legislation, and much anticipated FDA Clinical Studies of KRFI Remogen® Ibogaine ProDrug for Opioid Use Disorder for its anti-addiction efficacy studies.

​

 

KRFI’s current PPP Secretariat for the Round Table (PPP SRT) challenges for the establishment of the Opioid Abatement Matching Fund (OAMF) are initiative launched in conjunction to the efforts of W. Bryan Hubbard, former AG of Kentucky Opioid Abatement Advisory Commission (KOAAC) to be earmarked for Ibogaine FDA IND for Opioid Use Disorder Clinical Trial by building a stronger Private Public Sector Partnership through the Opioid Abatement Matching Fund (OAMF). Opioid Pandemics are critical ongoing topics in CA, CO, OR, OH, NY, NM, NV, and others for important US legislative bills are decriminalization bill for the ibogaine and psychedelics in wake of diverse non profit and industrial private sector clinical trials for psychedelic therapeutic with evidence based clinical trials and reports globally.

​

 

KRFI supports publications and reporting on the social movements of KRFI PPP SRT with UNODC, and its importance of the UN Convention on BioDiversity (UNCBD) and the Ibogaine and Psychedelic Medicinal for Access for Benefit Sharing (ABS) for Ibogaine and the psychedelic natural medicine Act and decriminalization of scheduled Psychedelic UN convention by UNODC. Global report on the Ibogaine and Psychedelics for Natural Medicine Health Act for OUD/SUD Therapeutics.